MolecularMD Revenue and Competitors

Location

$14M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MolecularMD's estimated annual revenue is currently $5M per year.(i)
  • MolecularMD received $2.0M in venture funding in February 2017.
  • MolecularMD's estimated revenue per employee is $77,500
  • MolecularMD's total funding is $14M.

Employee Data

  • MolecularMD has 65 Employees.(i)
  • MolecularMD grew their employee count by -7% last year.

MolecularMD's People

NameTitleEmail/Phone
1
VP, Development and Scientific AffairsReveal Email/Phone
2
VP, Global Medical DirectorReveal Email/Phone
3
Director, Business DevelopmentReveal Email/Phone
4
Director, Laboratory OperationsReveal Email/Phone
5
Assay Development ManagerReveal Email/Phone
6
Laboratory ManagerReveal Email/Phone
7
Senior Material Control SpecialistReveal Email/Phone
8
QA Auditor IReveal Email/Phone
9
Senior Scientist NGSReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.7M37-7%N/AN/A
Add Company

What Is MolecularMD?

MolecularMD Corporation develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly targeted cancer therapies. MolecularMD's assays incorporate both gold-standard and innovative technologies to provide highly sensitive, standardized, reliable results that support clinical development, regulatory approval, and commercialization of novel anticancer agents. A private company based in Portland, Oregon, MolecularMD was founded by Brian Druker, director of the Knight Cancer Center at Oregon Health & Science University and lead clinical investigator for Gleevec, and Sheridan G. Snyder, entrepreneur and founder of Genzyme Corporation and Upstate Biotechnology.

keywords:Biotechnology,Healthcare,Human Resources Hr,Medical Diagnostics,Pharmaceuticals

$14M

Total Funding

65

Number of Employees

$5M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MolecularMD News

2022-04-17 - Companion Diagnostics Market: Increase in Demand and ...

... Inc., MolecularMD Corporation, Ventana Medical Systems, Inc., Illumina, Inc., Life Technologies Corporation, Invivoscribe Technologies,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.2M6523%$16.5M
#2
$19.2M65-4%N/A
#3
$12.3M653%N/A
#4
$5.9M657%N/A
#5
$13.3M652%N/A

MolecularMD Funding

DateAmountRoundLead InvestorsReference
2009-02-04$3.0MUndisclosedArticle
2016-07-21$0.5MUndisclosedArticle
2017-02-15$2.0MUndisclosedArticle